ATI RN
Psychotropic Medication Questions
Question 1 of 5
On the basis of current knowledge of neurotransmitter effects, a nurse anticipates that the treatment plan for a patient with memory difficulties may include medications designed to:
Correct Answer: D
Rationale: The correct answer is D: prevent destruction of acetylcholine. Acetylcholine is a neurotransmitter essential for memory and learning. Medications that prevent its destruction can help improve memory function. Inhibiting GABA production (choice A) would not be beneficial for memory as GABA is an inhibitory neurotransmitter. Increasing dopamine sensitivity (choice B) is more related to motivation and reward processing rather than memory. Decreasing dopamine at receptor sites (choice C) may lead to movement disorders but is not directly related to memory function. Thus, choice D is the most appropriate option for addressing memory difficulties.
Question 2 of 5
A patient has taken many conventional antipsychotic drugs over years. The health care provider, who is concerned about early signs of tardive dyskinesia, prescribes risperidone (Risperdal). A nurse planning care for this patient understands that atypical antipsychotics:
Correct Answer: D
Rationale: The correct answer is D: produce fewer motor side effects. Atypical antipsychotics like risperidone have a lower risk of causing tardive dyskinesia compared to conventional antipsychotics. This is because atypical antipsychotics target both dopamine and serotonin receptors, leading to a reduced risk of motor side effects. Choices A, B, and C are incorrect because the cost, potency, and availability of atypical antipsychotics do not directly relate to the reduced risk of motor side effects associated with tardive dyskinesia.
Question 3 of 5
A patient wants to learn more about integrative therapies. Which resource should the nurse suggest for the most reliable information?
Correct Answer: D
Rationale: The correct answer is D: National Center for Complementary and Integrative Health (NCCIH). The NCCIH is a reputable organization that conducts research on integrative therapies, providing evidence-based information. They ensure the reliability and credibility of the information. The ANA (choice B) focuses more on nursing standards and policies, not specifically on integrative therapies. The FDA (choice C) regulates drugs and medical devices, not integrative therapies. The internet (choice A) is a vast source of information, but reliability can vary widely, making it less trustworthy compared to the NCCIH.
Question 4 of 5
A patient has tried a variety of CAM approaches to manage health concerns. The nurse asks, "How is going to CAM practitioners different from seeing your medical doctors?” The patient is most likely to respond, "The CAM practitioners
Correct Answer: B
Rationale: Step 1: CAM practitioners typically focus on holistic care and spend more time with patients compared to medical doctors. Step 2: By spending more time talking, CAM practitioners can gather detailed information about the patient's health concerns and lifestyle. Step 3: This allows for a more personalized approach to treatment, addressing not just symptoms but also underlying causes. Step 4: In contrast, medical doctors may have limited time for each patient due to the volume of patients they see. Step 5: Therefore, the patient is likely to respond that CAM practitioners spend more time talking with them, as it aligns with the holistic and personalized approach of CAM.
Question 5 of 5
A patient had a venous thrombosis 3 weeks ago and is now taking warfarin. When visiting the laboratory to have a prothrombin time drawn, the patient reports drinking ginseng tea to stimulate the immune system. Which nursing diagnosis applies?
Correct Answer: B
Rationale: The correct answer is B: Deficient knowledge related to potentially harmful drug interactions. The patient's use of ginseng tea can interact with warfarin, leading to decreased effectiveness and increased risk of bleeding. This nursing diagnosis is appropriate as the patient lacks knowledge about the potential harmful drug interactions. Impaired memory (choice A) is not relevant in this scenario. Ineffective denial (choice C) suggests the patient is not acknowledging the consequences, which is not evident. Effective management (choice D) does not apply as the patient is unknowingly engaging in a behavior that can affect the therapeutic regime. Therefore, choice B is the best option given the patient's situation.